Cargando…

Pangenomic antiviral effect of REP 2139 in CRISPR/Cas9 engineered cell lines expressing hepatitis B virus surface antigen

Chronic hepatitis B remains a global health problem with 296 million people living with chronic HBV infection and being at risk of developing cirrhosis and hepatocellular carcinoma. Non-infectious subviral particles (SVP) are produced in large excess over infectious Dane particles in patients and ar...

Descripción completa

Detalles Bibliográficos
Autores principales:	Angelo, Léna, Vaillant, Andrew, Blanchet, Matthieu, Labonté, Patrick
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10619774/ https://www.ncbi.nlm.nih.gov/pubmed/37910550 http://dx.doi.org/10.1371/journal.pone.0293167

Ejemplares similares

Nucleic acid polymer REP 2139 and nucleos(T)ide analogues act synergistically against chronic hepadnaviral infection in vivo in Pekin ducks
por: Quinet, Jonathan, et al.
Publicado: (2018)

Persistent Control of Hepatitis B Virus and Hepatitis Delta Virus Infection Following REP 2139‐Ca and Pegylated Interferon Therapy in Chronic Hepatitis B Virus/Hepatitis Delta Virus Coinfection
por: Bazinet, Michel, et al.
Publicado: (2020)

Analysis of bacterial pangenomes reduces CRISPR dark matter and reveals strong association between membranome and CRISPR-Cas systems
por: Rubio, Alejandro, et al.
Publicado: (2023)

Chromosome engineering in zygotes with CRISPR/Cas9
por: Boroviak, Katharina, et al.
Publicado: (2016)

Validation of Promoters and Codon Optimization on CRISPR/Cas9-Engineered Jurkat Cells Stably Expressing αRep4E3 for Interfering with HIV-1 Replication
por: Chupradit, Koollawat, et al.
Publicado: (2022)

The Impact of CRISPR-Cas System on Antiviral Therapy
por: Bayat, Hadi, et al.
Publicado: (2018)

The Application of CRISPR/Cas Systems for Antiviral Therapy
por: Baddeley, Helen J. E., et al.
Publicado: (2021)

CRISPR/Cas9 as an antiviral against Orthopoxviruses using an AAV vector
por: Siegrist, Cathryn M., et al.
Publicado: (2020)

Applications of CRISPR-Cas9 mediated genome engineering
por: Yang, Xiao
Publicado: (2015)

Systems Biology and Pangenome of Salmonella O-Antigens
por: Seif, Yara, et al.
Publicado: (2019)

CRISPR-Cas Targeting of Host Genes as an Antiviral Strategy
por: Chen, Shuliang, et al.
Publicado: (2018)

Oligodendrogenesis and myelination tracing in a CRISPR/Cas9-engineered brain microphysiological system
por: Romero, July Carolina, et al.
Publicado: (2023)

CRISPR/Cas9-Based Antiviral Strategy: Current Status and the Potential Challenge
por: Lee, Choongho
Publicado: (2019)

CRISPR/Cas9 engineering of a KIM-1 reporter human proximal tubule cell line
por: Veach, Ruth Ann, et al.
Publicado: (2018)

PB2139: MONITORING OLIGOSECRETORY MULTIPLE MYELOMA USING MALDI-TOF MASS SPECTROMETRY
por: Berlanga, Oscar, et al.
Publicado: (2023)

CRISPR-Cas-Based Engineering of Probiotics
por: Liu, Ling, et al.
Publicado: (2023)

Optimization of Genome Engineering Approaches with the CRISPR/Cas9 System
por: Li, Kai, et al.
Publicado: (2014)

Engineered CRISPR-Cas9 nucleases with altered PAM specificities
por: Kleinstiver, Benjamin P., et al.
Publicado: (2015)

Optimization of genome editing through CRISPR-Cas9 engineering
por: Zhang, Jian-Hua, et al.
Publicado: (2016)

Low‐gluten, nontransgenic wheat engineered with CRISPR/Cas9
por: Sánchez‐León, Susana, et al.
Publicado: (2017)

Highly parallel genome variant engineering with CRISPR/Cas9
por: Sadhu, Meru J., et al.
Publicado: (2018)

Protein Engineering Strategies to Expand CRISPR-Cas9 Applications
por: Ribeiro, Lucas F., et al.
Publicado: (2018)

Optimization of T4 phage engineering via CRISPR/Cas9
por: Duong, Michelle M., et al.
Publicado: (2020)

Engineering large-scale chromosomal deletions by CRISPR-Cas9
por: Eleveld, Thomas F, et al.
Publicado: (2021)

CRISPR-Cas9 delivery strategies with engineered extracellular vesicles
por: Lu, Yaoyao, et al.
Publicado: (2023)

Founder transformants of cotton (Gossypium hirsutum L.) obtained through the introduction of DS-Red, Rec, Rep and CRISPR/Cas9 expressing constructs for developing base lines of recombinase mediated gene stacking
por: Aslam, Sabin, et al.
Publicado: (2022)

Advancing chimeric antigen receptor T cell therapy with CRISPR/Cas9
por: Ren, Jiangtao, et al.
Publicado: (2017)

Therapeutic Antiviral Effect of the Nucleic Acid Polymer REP 2055 against Persistent Duck Hepatitis B Virus Infection
por: Noordeen, Faseeha, et al.
Publicado: (2015)

Efficient Genome Engineering of Toxoplasma gondii Using CRISPR/Cas9
por: Sidik, Saima M., et al.
Publicado: (2014)

Genome Engineering of Drosophila with the CRISPR RNA-Guided Cas9 Nuclease
por: Gratz, Scott J., et al.
Publicado: (2013)

Heritable Multiplex Genetic Engineering in Rats Using CRISPR/Cas9
por: Ma, Yuanwu, et al.
Publicado: (2014)

A CRISPR-Cas9 System for Genetic Engineering of Filamentous Fungi
por: Nødvig, Christina S., et al.
Publicado: (2015)

In vivo engineering of oncogenic chromosomal rearrangements with the CRISPR/Cas9 system
por: Maddalo, Danilo, et al.
Publicado: (2014)

Off-target Effects in CRISPR/Cas9-mediated Genome Engineering
por: Zhang, Xiao-Hui, et al.
Publicado: (2015)

CRISPR/Cas9-Based Cellular Engineering for Targeted Gene Overexpression
por: Osborn, Mark J., et al.
Publicado: (2018)

CRISPR-Cas9 In Situ engineering of subtilisin E in Bacillus subtilis
por: Price, Marcus A., et al.
Publicado: (2019)

CRISPR/Cas9 System: A Bacterial Tailor for Genomic Engineering
por: Lone, Bilal Ahmad, et al.
Publicado: (2018)

Profiling of engineering hotspots identifies an allosteric CRISPR-Cas9 switch
por: Oakes, Benjamin L, et al.
Publicado: (2016)

CRISPR/Cas9 Immune System as a Tool for Genome Engineering
por: Hryhorowicz, Magdalena, et al.
Publicado: (2016)

CRISPR/Cas9 Mediated Genome Engineering for Improvement of Horticultural Crops
por: Karkute, Suhas G., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_avfkflqjfjvcsn3v0sv6ibqua4